Health · 40 views
New survey highlights persistent cancer medication shortages across United States
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States.
Summary
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States. The data come from survey responses from pharmacy directors and other clinical and administrative leaders at NCCN Member Institutions from late August. According to the results, 100% of responding cancer centers are experiencing a shortage of at least one anticancer agent, with more than 20% of centers currently experiencing shortages of five or more different medications.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- CTE in NFL Players: What a New Study Tells Us -- And What It Doesn'tContinue reading
- Parents' Autoimmune Disease Linked to Kids' Type 1 Diabetes RiskContinue reading
- How an innate immune protein can control cholesterol, tumor growth and response to cancer therapyContinue reading
- Washington state resident dies from ‘severe illness’ after contracting bird fluContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow